Gemcitabine as first-line therapy for high-grade non-muscle invasive bladder cancer: results from a tertiary center in the contemporary BCG-shortage era

Jiping Zeng, Joel Funk, Benjamin R. Lee, Chiu-Hsieh Hsu, Edward M. Messing, Juan Chipollini